Novobiotic Pharmaceuticals is a privately held, preclinical-stage biopharmaceutical company dedicated to discovering and developing the next generation of antibiotics for multi-drug resistant (MDR) infections. Utilizing a novel proprietary technology platform, Novobiotic aims to address the urgent global health threat of antimicrobial resistance by advancing innovative therapies from discovery through preclinical development. Their primary focus is on identifying unique antibacterial agents with novel mechanisms of action.
The Woburn headquarters serves as the central hub for all research and development activities, laboratory operations, and corporate administration for Novobiotic Pharmaceuticals.
The facility includes modern, fully-equipped laboratories for microbiology, molecular biology, and chemistry, as well as office space, all designed to support cutting-edge antibiotic research. It is situated in a commercial life sciences building.
Novobiotic fosters a collaborative, innovative, and science-driven work culture. Employees are typically highly specialized and dedicated to the company's mission of combating antimicrobial resistance. The environment encourages scientific rigor and problem-solving.
This location is strategically important, providing access to a rich talent pool, research institutions, and a supportive ecosystem for biopharmaceutical innovation. It is where the core scientific breakthroughs and development of their antibiotic candidates occur.
While Novobiotic Pharmaceuticals is headquartered in the United States, its mission to combat antimicrobial resistance is global in scope. The company's research and development efforts aim to produce novel antibiotics that can address worldwide health challenges. Its global presence is primarily through scientific collaborations, participation in international conferences, and potential future partnerships with pharmaceutical companies for global clinical trials and commercialization of its products.
12 Gill Street, Suite 2600
Woburn
MA
USA
Address: N/A
Operations are concentrated at the primary headquarters to ensure close collaboration and efficiency in their R&D efforts.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, NovoBiotic Pharmaceuticals' leadership includes:
NovoBiotic Pharmaceuticals has been backed by several prominent investors over the years, including:
There have been no publicly announced major executive new hires or departures at Novobiotic Pharmaceuticals in the last 12 months. The current leadership team appears stable based on information from the company's official channels.
Discover the tools NovoBiotic Pharmaceuticals uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
The email format for Novobiotic Pharmaceuticals likely follows common corporate structures. Based on industry standards and the company domain 'novobiotic.com', typical formats include combining the first initial and last name, or first name and last name separated by a period.
[first_initial][last]@novobiotic.com
Format
dhughes@novobiotic.com
Example
85%
Success rate
Novobiotic Pharmaceuticals Official Website • June 15, 2023
Novobiotic Pharmaceuticals announced the presentation of compelling preclinical data for its lead candidate, NBT-002, at the ASM Microbe 2023 conference. NBT-002 is a novel antibiotic agent targeting multi-drug resistant (MDR) Gram-negative bacteria. The data highlighted its potent activity and potential to address significant unmet medical needs in treating severe infections....more
Novobiotic Pharmaceuticals Official Website • September 6, 2022
Novobiotic Pharmaceuticals announced its participation and presentation at the World AMR Congress 2022. This engagement provided an opportunity to share insights on their research in novel antibiotic discovery and contribute to the global discussion on combating antimicrobial resistance....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including NovoBiotic Pharmaceuticals, are just a search away.